O’Hare AM, Glidden DV, Fox CS, Hsu CY (2004) High prevalence of peripheral arterial disease in persons with renal insufficiency: results from the National Health and Nutrition Examination Survey 1999–2000. Circulation 109(3):320–323

Article  PubMed  Google Scholar 

Meyer A, Fiessler C, Stavroulakis K, Torsello G, Bisdas T, LangCRITISCH collaborators W (2018) Outcomes of dialysis patients with critical limb ischemia after revascularization compared with patients with normal renal function. J Vasc Surg 68(3):822–829

Article  PubMed  Google Scholar 

Meyer A, Schilling A, Kott M, Rother U, Lang W, Regus S (2018) Open versus endovascular revascularization of below-knee arteries in patients with end-stage renal disease and critical limb ischemia. Vasc Endovascular Surg 52(8):613–620

Article  PubMed  Google Scholar 

Ramanan B, Jeon-Slaughter H, Chen X, Modrall JG, Tsai S (2019) Comparison of open and endovascular procedures in patients with critical limb ischemia on dialysis. J Vasc Surg 70(4):1217–1224

Article  PubMed  Google Scholar 

Aboyans V, Ricco JB, Bartelink MEL, Björck M, Brodmann M, Cohnert T, Collet JP, Czerny M, De Carlo M, Debus S, Espinola-Klein C, Kahan T, Kownator S, Mazzolai L, Naylor AR, Roffi M, Röther J, Sprynger M, Tendera M, Tepe G, Venermo M, Vlachopoulos C, Desormais I, ESC Scientific Document Group (2018) 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J 39(9):763–816

Article  PubMed  Google Scholar 

Conte MS, Bradbury AW, Kolh P, White JV, Dick F, Fitridge R, Mills JL, Ricco JB, Suresh KR, Murad MH, GVG Writing Group (2019) Global vascular guidelines on the management of chronic limb-threatening ischemia. J Vasc Surg 69(6S):3S-125S

Article  PubMed  PubMed Central  Google Scholar 

Schneider PA, Laird JR, Tepe G, Brodmann M, Zeller T, Scheinert D, Metzger C, Micari A, Sachar R, Jaff MR, Wang H, Hasenbank MS, Krishnan P, IN.PACT SFA Trial Investigators (2018) Treatment effect of drug-coated balloons is durable to 3 years in the femoropopliteal arteries: long-term results of the IN.PACT SFA randomized trial. Circ Cardiovasc Interv 11(1):e005891

Article  PubMed  PubMed Central  Google Scholar 

Jaff MR, Rosenfield K, Scheinert D, Rocha-Singh K, Benenati J, Nehler M, White CJ (2015) Drug-coated balloons to improve femoropopliteal artery patency: rationale and design of the LEVANT 2 trial. Am Heart J 169(4):479–485

Article  PubMed  Google Scholar 

Sachar R, Soga Y, Ansari MM, Kozuki A, Lopez L, Brodmann M, Schroë H, Ramanath VS, Diaz-Cartelle J, Zeller T, RANGER II SFA Investigators (2021) 1-year results from the ranger ii sfa randomized trial of the ranger drug-coated balloon. JACC Cardiovasc Interv 14(10):1123–1133

Article  PubMed  Google Scholar 

Ansel GM, Brodmann M, Keirse K, Micari A, Jaff MR, Rocha-Singh K, Fernandez EJ, Wang H, Zeller T, IN.PACT Global Study Investigators (2018) Drug-Coated Balloon Treatment of Femoropopliteal Lesions Typically Excluded From Clinical Trials: 12-Month Findings From the IN.PACT Global Study. J Endovasc Ther 25(6):673–682

Article  PubMed  Google Scholar 

Hayakawa N, Takahara M, Nakama T, Horie K, Takanashi K, Kanagami T, Ichihara S, Arakawa M, Tobita K, Mori S, Iwata Y, Suzuki K, Kanda J (2022) Clinical outcome of drug-coated balloons in patients with femoropopliteal chronic total occlusive lesions: results from the multicenter EAGLE study. CVIR Endovasc 5(1):51

Article  PubMed  PubMed Central  Google Scholar 

Rockwood K, Song X, MacKnight C, Bergman H, Hogan DB, McDowell I, Mitnitski A (2005) A global clinical measure of fitness and frailty in elderly people. CMAJ 173(5):489–495

Article  PubMed  PubMed Central  Google Scholar 

Rocha-Singh KJ, Zeller T, Jaff MR (2014) Peripheral arterial calcification: prevalence, mechanism, detection, and clinical implications. Catheter Cardiovasc Interv 83(6):E212–E220

Article  PubMed  Google Scholar 

Fujihara M, Takahara M, Sasaki S, Nanto K, Utsunomiya M, Iida O, Yokoi Y (2017) Angiographic dissection patterns and patency outcomes after balloon angioplasty for superficial femoral artery disease. J Endovasc Ther 24(3):367–375

Article  PubMed  Google Scholar 

Torsello G, Stavroulakis K, Brodmann M, Micari A, Tepe G, Veroux P, Benko A, Choi D, Vermassen FEG, Jaff MR, Guo J, Dobranszki R, Zeller T, Global Investigators INPACT (2020) Three-year sustained clinical efficacy of drug-coated balloon angioplasty in a real-world femoropopliteal cohort. J Endovasc Ther 27(5):693–705

Article  PubMed  Google Scholar 

Thieme M, Von Bilderling P, Paetzel C, Karnabatidis D, Perez Delgado J, Lichtenberg M, Lutonix Global SFA Registry Investigators (2017) The 24-Month Results of the Lutonix Global SFA Registry: Worldwide Experience with Lutonix Drug-Coated Balloon. JACC Cardiovasc Interv 10(16):1682–1690

Article  PubMed  Google Scholar 

Chou HH, Huang HL, Hsieh CA, Jang SJ, Tzeng IS, Ko YL (2018) Drug-coated balloon vs conventional balloon angioplasty in dialysis patients with symptomatic femoropopliteal disease- a matched comparison. Circ J 82(7):1908–1916

Article  CAS  PubMed  Google Scholar 

Schillinger M, Sabeti S, Loewe C, Dick P, Amighi J, Mlekusch W, Schlager O, Cejna M, Lammer J, Minar E (2006) Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 354(18):1879–1888

Article  CAS  PubMed  Google Scholar 

Laird JR, Katzen BT, Scheinert D, Lammer J, Carpenter J, Buchbinder M, Dave R, Ansel G, Lansky A, Cristea E, Collins TJ, Goldstein J, Jaff MR, RESILIENT Investigators (2010) Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv 3(3):267–276

Article  PubMed  Google Scholar 

Fujihara M, Higashimori A, Kato Y, Taniguchi H, Iwasaki Y, Amano T, Sumiyoshi A, Nishiya D, Yokoi Y (2016) Nitinol stent implantation for femoropopliteal disease in patients on hemodialysis: results of the 3-year retrospective multicenter APOLLON study. Heart Vessels 31(9):1476–1483

Article  PubMed  Google Scholar 

Ito R, Ishii H, Oshima S, Nakayama T, Takahashi H, Sakakibara T, Kakuno M, Murohara T (2021) Long-term clinical outcomes after self-expandable bare nitinol stent implantation for femoropopliteal occlusive disease in hemodialysis patients. Catheter Cardiovasc Interv 97(2):318–324

Article  PubMed  Google Scholar 

Shishehbor MH, Scheinert D, Jain A, Brodmann M, Tepe G, Ando K, Krishnan P, Iida O, Laird JR, Schneider PA, Rocha-Singh KJ, Zeller T (2023) Comparison of drug-coated balloons vs bare-metal stents in patients with femoropopliteal arterial disease. J Am Coll Cardiol 81(3):237–249

Article  CAS  PubMed  Google Scholar 

Kurata N, Iida O, Takahara M, Asai M, Okamoto S, Ishihara T, Nanto K, Tsujimura T, Hata Y, Toyoshima T, Higashino N, Nakao S, Mano T (2023) Comparing predictors influencing restenosis following high-dose drug-coated balloon angioplasty and fluoropolymer-based drug-eluting stenting in femoropopliteal artery lesions. J Endovasc Ther. https://doi.org/10.1177/15266028231209234

Article  PubMed  Google Scholar 

Iida O, Takahara M, Soga Y, Yamaoka T, Fujihara M, Kawasaki D, Ichihashi S, Kozuki A, Nanto S, Sakata Y, Mano T, CAPSICUM Investigators (2022) 1-year outcomes of fluoropolymer-based drug-eluting stent in femoropopliteal practice: predictors of restenosis and aneurysmal degeneration. JACC Cardiovasc Interv 15(6):630–638

Article  PubMed  Google Scholar 

Byrne RA, Joner M, Alfonso F, Kastrati A (2014) Drug-coated balloon therapy in coronary and peripheral artery disease. Nat Rev Cardiol 11(1):13–23

Article  CAS  PubMed  Google Scholar 

Soga Y, Takahara M, Iida O, Tomoi Y, Kawasaki D, Tanaka A, Yamauchi Y, Tobita K, Kozuki A, Fujihara M, Ando K, POPCORN Investigators (2023) Vessel patency and associated factors of drug-coated balloon for femoropopliteal lesion. J Am Heart Assoc 12(1):e025677

Article  PubMed  Google Scholar 

Shimada T, Shima Y, Takahashi K, Miura K, Takamatsu M, Ikuta A, Habara S, Tanaka H, Goto T, Izumiya Y, Kadota K (2022) Delayed stenosis regression after drug-coated balloon angioplasty for femoropopliteal artery lesions. Heart Vessels 37(5):730–737

Article  PubMed  Google Scholar 

Mori S, Takahara M, Nakama T, Tobita K, Hayakawa N, Iwata Y, Horie K, Suzuki K, Yamawaki M, Ito Y (2023) Impact of calcification on clinical outcomes after drug-coated balloon angioplasty for superficial femoral artery disease: assessment using the peripheral artery calcification scoring system. Catheter Cardiovasc Interv 101(5):892–899

Article  PubMed  Google Scholar 

Mori S, Yamawaki M, Fukagawa T, Yamaguchi K, Mizusawa M, Shirai S, Honda Y, Tsutsumi M, Kobayashi N, Ito Y (2023) Impact of “black rock” on clinical outcomes after endovascular therapy for de novo calcified femoropopliteal lesions. Heart Vessels 38(11):1356–1363

Article  PubMed  Google Scholar 

Shammas NW, Purushottam B, Shammas WJ, Christensen L, Shammas G, Weakley D, Jones-Miller S, JET-RANGER Investigators (2022) Jetstream atherectomy followed by paclitaxel-coated balloons versus balloon angioplasty followed by paclitaxel-coated balloons: twelve-month exploratory results of the prospective randomized JET-RANGER study. Vasc Health Risk Manag 18:603–615

Article  PubMed